EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

03/10

Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.

The current Board comprises: • Chairman and Executive Director: Yifang Wu • Executive Directors: Yongqing Luo, Ian Ying Woo • Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun • Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang

The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1127952348"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127952348\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127952348?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127952348","market":"us","top_or_hot":-1,"title":"EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results","media":"Bulletin Express","content":"<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1127952348","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127952348","pubTimestamp":1773133437,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"EVEREST MED(01952)定于2026年3月25日召开董事会批准2025财年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.\nThe current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang\nThe announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}